Beginning with migraine and chronic nasal inflammatory diseases such as chronic rhinosinusitis, we plan to reshape the landscape for multiple underserved conditions by leveraging the nose for drug delivery. OptiNose developed a way to deliver the right drugs to the right places, more reliably and consistently, allowing us to use known molecules in new ways that transcend the limitations of other available therapies.
Our mission is to improve quality of life for patients by providing better alternatives to existing treatments, including prescription medications, vaccines, biologics and over-the-counter medications. The approval by the FDA of AVP-825, our licensed product for the acute treatment of migraines, demonstrates our ability to effectively realize our vision.
From the husband-and-wife team who founded OptiNose 2000, to today’s cadre of experienced senior leaders, we do things differently. Hailing from industry-leading companies, our leadership team is applying its extensive skills and experience to get things done the right way. Guided by ideals such as friendship, openness, possibility thinking, fearless conversations and authenticity, we continue to seek partners and future colleagues who share these views.
We have a near-term plan, a long-term vision and a strong team to guide us. Keep an eye on us as we move forward to meet the needs of today’s — and tomorrow’s — healthcare challenges.